Phase 2 Stroke Trial, Recruiting NCT06752720 Sponsor: Hokkaido University Hospital Condition: Stroke
Back to Stroke

Phase 2 Stroke Trial, Recruiting

NCT06752720
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 20 and 70 years
  • People who were diagnosed with an ischemic stroke (a stroke caused by a blocked blood vessel) between 6 months and 5 years ago
  • People whose stroke affected a specific blood vessel area on one side of the brain (the internal cerebral artery territory)
  • People with moderate to severe effects from their stroke, based on two specific medical scoring scales (mRS score of 3 or 4, and Brunnstrom stage III or IV — confirm with trial site for what these mean in your situation)
  • People whose brain scan shows a specific measurement called a DTI-RAINBOW value above 70% at the screening MRI
  • People who had little to no disability before their stroke (pre-stroke mRS score of 0 or 1)
  • People who are able to give their own informed consent to participate

Who may not be able to join:

  • People with severe stiffness or tightening of the muscles in their lower legs that significantly limits movement
  • People with low red blood cell levels (anaemia)
  • People with a low platelet count in their blood
  • People with serious heart conditions, such as heart disease or heart failure
  • People with significant liver or kidney problems, based on blood test results
  • People with a history of cancer
  • People who carry certain infectious diseases, including syphilis, hepatitis B, hepatitis C, HIV, HTLV-1, or parvovirus B19
  • People who are pregnant, breastfeeding, or planning to become pregnant during the study period
  • People with a known serious allergy to any substances used in the study
  • People for whom an MRI scan is not safe (for example, due to certain metal implants)
  • People who have had a seizure within the past 2 years
  • People who weigh less than 45 kg (if male) or less than 40 kg (if female)
  • People who have taken part in another clinical trial in the past 90 days, or who plan to join another clinical trial in the future
  • People whose overall health condition, in the treating doctor's judgement, would put them at undue risk by participating

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +81-11-706-1161

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Hokkaido University Hospital
Registry
ClinicalTrials.gov
Start date
1 December 2024
Est. completion
31 December 2025

Where this trial is recruiting

🇯🇵 Japan

Primary endpoints

Efficacy of HUNS001-01 administration

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov